Continue reading Stack3d

Gains In Bulk refines its eight-month-old pre-workout and squeezes in 50% more servings

Gains In Bulk No Matter What 2

It was only seven months ago that Gains In Bulk entered the fast-paced category of stimulant pre-workouts in the uniquely named competitor, No Matter What. It wasn’t packed to the brim with hefty dosages, but everything was at a reasonable amount, enough to get the job done in the areas it was aiming to hit. That includes 4g of citrulline to boost muscle pumps, 300mg of alpha-gpc for focus, and 300mg of enfinity paraxanthine for smooth, lasting energy.

While No Matter What only came to market at the end of last year, Gains In Bulk has already seen fit to make some changes and relaunch its original pre-workout in version two. The brand has mostly refined the supplement, keeping a lot of the original ingredients as well as their dosages. Gains has also removed a few components, again, refining the product, putting more attention on supporting immediate and noticeable benefits for your workout.

Gains In Bulk No Matter What 2 Label

Glycerol has been dropped from Gains In Bulk’s No Matter What pre-workout, leaving behind just pure citrulline for the pumps, but at a 50% higher dosage at 6g. Beta-alanine is still in there at its original 3.2g to power performance, plus 200mg of pink Himalayan salt to support hydration and endurance. Leucine and the nutrient optimizers ribose and lipase are out as well, with the remaining ingredients being alpha-gpc, theanine, and enfinity paraxanthine, all at the amounts of the first No Matter What.

Another notable change in No Matter What is Gains In Bulk has increased the servings to 30 per bottle rather than 20, but that has come with a price increase to $60. Fortunately, like when the pre-workout first came to market around Black Friday, version two has launched alongside the brand’s Prime Day sale. Starting tomorrow through to Friday, at gainsinbulk.com, the refined No Matter What is 25% off, bringing it down to $45 each and $39 on subscription.

COMMENTS